Greater than 50% of ClinOne trial experience is supporting the unique requirements of oncology trial patients, caregivers, and site staff
BOSTON, July 19, 2022 /PRNewswire-PRWeb/ -- ClinOne, the true single platform for adaptive experiences in clinical trials, will showcase the value of technology for cancer studies – including eConsent, trial awareness, and patient ride – at Clinical Trials in Oncology East Coast, July 19-20, 2022 at the Boston Marriott Newton.
While the ClinOne platform spans therapeutic areas, it is especially beneficial for studies that face recruitment and awareness, consent and enrolment, and patient retention and compliance challenges:
- Recruitment and awareness - In hard-to-recruit patient populations, raising awareness of a clinical trial with the local HCP community can generate peer-to-peer conversations that make it easier to connect people to the study, reaching huge and diverse patient pools through trusted care team relationships.
- Enrolment and consent – Cancer studies have notoriously complex consent processes with multiple ICF types and frequent amendments that place a significant burden not only on patients but also site staff to manage version control and re-consent status.
- Patient retention and compliance – Keeping patients engaged in multi-year studies in the face of the many other priorities they are focused on outside of the trial can be supported by patient ride, background medication adherence, virtual visits when appropriate, and more.
"Oncology studies – and more importantly the people who participate in and run them – have specific challenges and requirements that demand and deserve special attention," said Andrea Valente (LinkedIn), CEO of ClinOne. "The lives of cancer patients are very full and often complex, and they know best what will work for them at any given time. We are excited about the power of adaptive experiences because they make multiple workflows available, whether using technology or not, so they can make the right decision on how to participate in a way that doesn't get in the way of their daily lives."
Featuring solutions for trial awareness, eConsent, and patient ride, the ClinOne platform helps oncology patients and families connect with their research site and take control of their trial experience. The platform also features a self-dosing compliance manager, and eDiaries for QOL questionnaires. Additionally, ClinOne offers the industry's fastest deployment, often in less than 4 weeks so participants can experience benefits faster than ever.
Learn how ClinOne will help you connect, inform, and empower patients to get the results you need and the experience patients deserve at http://www.clinone.com.
About ClinOne
ClinOne provides adaptive experiences for participants in clinical trials. By offering choice to patients, caregivers, and site staff, our technology makes it easier to stay active, compliant, and comfortable in a trial – thereby expanding enrollment access, reducing drop-out rate, and shortening conduct timelines. Our true single platform features solutions for local HCP trial awareness, remote and on-site eConsent, Uber Health, medication adherence, and a DCT portal. ClinOne stands alone with the industry's fastest implementation (average 2-4 weeks), cost-efficient scale, and seamless API integrations for complex therapeutic areas such as Oncology, CNS, and Rare Disease in over 60 languages. To learn why more than 55 sponsors and CROs trust ClinOne in 100+ currently active studies to connect, inform, and empower participants to take control of their clinical trial experience, begin a conversation with our experts at http://www.clinone.com.
Media Contact
Brenda Nashawaty, ClinOne, 1 617-688-3253, [email protected]
SOURCE ClinOne
Share this article